Erratum to "Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NTproBNP" (DOI:10.1016/j.cca.2006.01.017);Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP

Clinica Chimica Acta

Volumn 369, Issue 1, 2006, Pages 95-99

  Chien, Tzu I ^a   Chen, Hui hou ^a   Kao, Jau Tsuen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

BNP; Congestive heart failure; Method comparison; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; EDETIC ACID; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; IMMUNOREACTIVITY; MEASUREMENT; PLASMA; PRIORITY JOURNAL; PROTEIN STABILITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 33646869681     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.04.010     Document Type: Erratum

References (21)

1. Davis R.C., Hobbs F.D.R., and Lip G.Y.H. Clinical review: ABC of heart failure. BMJ 320 (2000) 39-42
2. Remme W.J., and Swedberg K. Task force report. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
3. De Bold A.J. Atrial natriuretic factor: a hormone produced by the heart. Science 230 (1985) 767-770
4. Valli N., Gobinet A., and Bordenare L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 134 (1999) 437-444
5. Hunt P.J., Espiner E.A., Nicholls M.G., Richards A.M., and Yandle T.G. The role of the circulation in processing pro-brain natriuretic peptide (NT-proBNP) to amino-terminal BNP and BNP-32. Peptides 18 (1997) 1475-1481
6. Yandle T.G. Biochemistry of natriuretic peptides. J Intern Med 235 (1994) 561-576
7. Davidson N.C., and Struthers A.D. Brain natriuretic peptide. J Hypertens 12 (1994) 329-336
8. Kambayashi Y., Nakao K., Mukoyama M., et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 259 (1990) 341-345
9. Sudoh T., Maekawa K., Kojima M., Minamino N., Kangawa K., and Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159 (1989) 1427-1434
10. Clerico A., Iervasi G., Del Chicca M.G., et al. Circulating concentrations of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21 (1998) 170-179
11. Hobbs F.D.R., Davis R.C., Roalfe A.K., Hare R., Davies M.K., and Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 324 (2002) 1498-1500
12. Passing H., and Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry: Part I. J Clin Chem Clin Biochem 21 (1983) 709-720
13. Miller W.L., Burnett J.C., Hartman K.A., et al. Lower rather than higher levels of B-type natriuretic peptides (NT-Pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol 96 (2005) 837-841
14. Wu A.H., Smith A., Wieczorek S., et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 (2003) 628-631
15. Shimizu H., Aono K., Masuta K., Asada H., Misaki A., and Teraoka H. Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 285 (1999) 169-172
16. Shimizu H., Aono K., Masuta K., Asada H., Misaki A., and Teraoka H. Degradation of human brain natriuretic peptide by contact activation of blood coagulation system. Clin Chim Acta 305 (2001) 181-186
17. Dasgupta A., Chow L., Tso G., and Nazareno L. Stability of NT-proBNP in serum specimens collected in Becton Dickinson Vacutainer (SST) tubes. Clin Chem 49 (2003) 958-960
18. van der Merwe D.E., Henley R., Lane G., et al. Effect of different sample types and stability after blood collection of N-Terminal Pro-B-Type natriuretic peptide as measured with Roche Elecsys system. Clin Chem 50 (2004) 779-780
19. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
20. Groenning B.A., Raymond I., Hildebrandt P.R., Nilsson J.C., Baumann M., and Pedersen F. The influence of age, sex and other variables on the plasma concentration of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
21. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta in press, doi:10.1016/j.cca.2005.11.005. [electronic publication ahead of print, Dec. 14 2005; PMID:16360137].